NCT00110903View on ClinicalTrials.gov

Treatment for Subjects With Active Rheumatoid Arthritis (RA)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Etanercept Liquid

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00110903 - Treatment for Subjects With Active Rheumatoid Arthritis (RA) | Biotech Hunter | Biotech Hunter